We are live on ! Find out more

Hims & Hers Health

HIMS

Market cap $6.42B

27.51 USD

+0.07

0.26%

At close Updated Sep 11, 4:00 PM EDT

Pre-market

After hours

27.48

-0.03

0.11%

1 day

0.26%

5 days

-0.79%

1 month

-9.83%

3 months

-4.71%

6 months

6.3%

Year to date

-17.66%

1 year

-46.85%

5 years

210.15%

10 years

180.71%

About: Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Employees: 2,442

Healthcare Drug Manufacturers - Specialty & Generic

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 18.3%

Neutral 67.9%

Negative 13.8%

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

NEW YORK, Sept. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

HIMS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between August 4, 2025 and July 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - September 12, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (""Hims" or the "Company") (NYSE: HIMS) and reminds investors of the November 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

HIMS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

NEW YORK and NEW ORLEANS, Sept. 11, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors to Contact the Firm Before the Deadline on November 2, 2026 for a Leadership Role

New York, New York--(Newsfile Corp. - September 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us.

Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors to Contact the Firm Before the Deadline on November 2, 2026 for a Leadership Role

Hims & Hers Health (HIMS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline

San Francisco, California--(Newsfile Corp. - September 11, 2026) - Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct. Hagens Berman, which is actively investigating the alleged claims, encourages HIMS investors who suffered substantial losses to submit your losses now.

Hims & Hers Health (HIMS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - September 11, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Hims securities between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period").

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Kaplan Fox Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investors of a Securities Class Action Deadline on November 2, 2026

NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the “Class Period”).

Kaplan Fox Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investors of a Securities Class Action Deadline on November 2, 2026

HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO--(BUSINESS WIRE)---- $HIMS #HIMS--The case alleges Hims & Hers and its top executives made false and/or misleading statements to investors.

HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces

Kaplan Fox Advises Hims & Hers Health, Inc. (HIMS) Investors to Act Before the Lead Plaintiff Deadline on November 2, 2026

New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us.

Kaplan Fox Advises Hims & Hers Health, Inc. (HIMS) Investors to Act Before the Lead Plaintiff Deadline on November 2, 2026

Hims & Hers Health, Inc. (HIMS) Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

Did you buy HIMS securities between August 4, 2025 and July 29, 2026 ? Affected HIMS Investor Summary Who: Hims & Hers Health, Inc. (NYSE: HIMS) What: Securities fraud class action lawsuit filed Class Period: August 4, 2025 through July 29, 2026 Deadline to Seek Lead Plaintiff Status: November 2, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's deceptive and unlawful privacy practices Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options Radnor, Pa.

Hims & Hers Health, Inc. (HIMS) Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

See News Rankings

Price charts implemented using Lightweight Charts™